Women with high serum IGFBP-3 levels had significantly lower rates of incident oncogenic HPV detection, and a lower incidence of oncogenic HPV-positive SIL, than woman with low serum IGFBP-3 levels. This evidence concerns the gene IGFBP3 and squamous cell intraepithelial neoplasia.